NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of… Apr 19, 2022
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate… Nov 23, 2021
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine Nov 5, 2021
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr.… Sep 22, 2021
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division Aug 5, 2021
PharmaTher Expands Patent Portfolio for Ketamine and Repurposing of Psychedelics with panaceAI™ Apr 27, 2021
